ESMO Immuno Oncology Congress 2017
Oncologists of today must adapt to rapid changes in practice. The promising results of immunotherapies in oncology are generating increasing interest from the oncology community and have the potential to become the standard of care.
This year sees the launch of the ESMO Immuno Oncology Congress, the new highly-focused meeting devoted entirely to the development and use of immunotherapies against cancer.
The creation of the ESMO Immuno Oncology Congress reflects ESMO’s commitment to providing oncologists who need to learn how to apply the latest standards of care in the immunotherapy of cancer with a comprehensive update in an environment rich with highly specialised professionals.